Forgot password?
Login / Register
Hepatitis, recently identified by the World Health Organization as a matter of global concern, now has its own mobile app.
Antimicrobial Therapy, Inc., the publisher of The Sanford Guide, a reference for infectious disease treatment, recently announced the release of the Sanford Guide to Hepatitis Diagnosis and Treatment. The first mobile app of its kind for hepatitis treatment, it was unveiled at last week’s 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Chicago.
The app is designed to give physicians treating Hepatitis patients real-time access to treatment options and other clinical decision support tools.
"A revolution is occurring in the treatment of Hepatitis C virus infections, similar in magnitude to the rapid change in HIV therapy in the mid-1990s," said Jeb Sanford, the guide’s managing editor, in a press release. "A major difference between HIV therapy and Hepatitis C therapy is that patients can be cured of Hepatitis C infections. New drugs approved in 2011 are transforming therapeutic approaches to Hepatitis C treatment and many more new drugs are in development."
The guide covers Hepatitis A treatment of acute infections; Hepatitis B treatment of chronic infections, management of exposure and prophylaxis in transplant patients; Hepatitis C diagnosis, epidemiology, natural history, clinical presentation, treatment settings and treatment; Hepatitis immunization recommendations; and comprehensive drug information for anti-Hepatitis agents, including use, dosage, dose adjustments, adverse effects, pharmacology and major interactions with other drugs.
The app is available on Apple’s App Store and the Android Market.
More information about formatting options
